SEBI Registration No - INA000003197 Investment in stock and commodity market are subject to market risk. Please do not trade on those tips which are not provided through SMS.


Dr lal

Dr. Lal PathLabs surges 14% after strong Q4 numbers

Shares of Dr. Lal PathLabs (DLPL), which posted good results yesterday, surged as high as Rs930 intraday. That’s 15% intraday gains.

DLPL reported 21.3% and 27.2% yoy growth in the revenue and PAT respectively. Margins were at 24% in Q4FY18 vs. 22.7% in Q4FY17.

The management in its conference call sounded optimistic on the business post the commencement of the Kolkata reference lab and have guided ~15% volume growth in FY19E. They have also shown their interest in growing business inorganically, which we believe will help in gaining market share in the competitive market.

The stock is currently trading at Rs880, up 9% from yesterday’s close. We have a target price of Rs963 on DLPL.

Read DLPL’s Q4 result review on our website.

On a one MISSED CALL on @9039006355 you can have your Free Trials for two days in Share Market so why are you waiting for, Hurry up! SUBSCRIBE US >> Bonaz Capital